HOME >> MEDICINE >> NEWS
C-reactive proteins: Should everyone be tested?

(Philadelphia, PA) -- In the last year, a number of studies have focused on the C-reactive protein (CRP) inflammatory risk factor for heart disease. Using high-sensitivity assays (hsCRP), we are able to measure CRP at lower levels than previously possible. These low levels of CRP (hsCRP) are related to chronic, low grade inflammation, which is associated with heart disease. Many of these studies reported on the relationship of hsCRP to first myocardial or anginal attack, recurrence of coronary heart disease incidents, and increased prognosis of heart disease when elevated hsCRP exists with other risk factors. Other published materials have focused on the laboratory methods used for identifying hsCRP, and have expressed concern about results that stem from using different test methods to identify hsCRP. A Cardiac Risk Survey released earlier this year by the College of American Pathologists (CAP) underscored the need for standardizing the results of five different classes used by labs to identify hsCRP. The Centers for Disease Control and Prevention (CDC) have issued recommendations to address these concerns.

Presentation at the 55th Annual AACC Meeting

How important is hsCRP as an indicator of cardiovascular disease? What is the role of laboratories and are readings affected by different laboratory methods and a lack of standardization? The Centers for Disease Control and Prevention (CDC) has examined these questions and developed recommendations for the public and leaders of the nation's clinical laboratories.

These recommendations will be discussed by Gerald R. Cooper, MD, PhD, of the Centers for Disease Control and Prevention, Atlanta, GA. Dr. Cooper will deliver his remarks entitled, "C-Reactive Protein: A New Inflammatory Risk Factor for Cardiovascular Disease," during the 55th Annual Meeting of the American Association of Clinical Chemistry (AACC) being held July 20-24, 2003 at the Pennsylvania Convention Center, Philadelphia
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Association for Clinical Chemistry
21-Jul-2003


Page: 1 2 3

Related medicine news :

1. Vitamin C reduces level of C-reactive protein, finds UC Berkeley-led study
2. C-reactive proteins do not predict early osteoarthritis
3. C-reactive protein more than a heart disease marker
4. High levels of C-reactive protein indicate early heart disease
5. Should medical students have earlier contact with patients?
6. Should nurses conduct breast cancer follow-up visits?
7. Should compulsory screening of immigrants be part of UK public health policy?
8. Should the standard guidelines for assessing prostate cancer control be changed?
9. Should living liver donation be available in the NHS?
10. Should ambulance crews perform emergency breathing procedure?
11. Should people with dementia be electronically tagged?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... ... March 01, 2017 , ... Breast Surgeon, Dr. Dennis Holmes of ... stage breast cancer and where it fits in the treatment paradigm at Susan G. ... .” The event brings together leading cancer and wellness experts to share the latest ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... increase colorectal cancer screening rates by supporting the 80% by 2018 initiative, led ... (CDC) and the National Colorectal Cancer Roundtable (an organization co-founded by ACS and ...
(Date:3/1/2017)... ... March 01, 2017 , ... “There is Comfort for the Soul”: a ... author in their all-too-brief time together, and the soul-healing comfort provided by God’s presence ... creation of published author, Jerie A. Tau, a dog-loving medical professional whose work takes ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Letter of Love”: a tale of ... Teresa Hamilton, survivor of the Civil War in El Salvador, wife, mother, and co-founder ... of fifteen. I dedicated myself to serve in very poor communities, and I study ...
(Date:2/28/2017)... (PRWEB) , ... March 01, 2017 , ... ... the acquisition of SmarterMe, a personal assistant for sales powered by an intelligent ... enterprises to work smarter. , SmarterMe is built grounds up keeping individual users ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Research and Markets has announced the addition of the "Global ... their offering. ... This analysis is one of the most accurate studies performed using ... data derived from varied research sources to present unique and reliable ... during the next five years, including a deep dive analysis of ...
(Date:3/1/2017)... 1, 2017 Utilizing a cloud-based, HIPAA-compliant ... three-phase program that offers providers the ability to ... if desired – move toward a self-distribution model ... episode of care. "The reality is ... to decrease," says Amin Rahme , president ...
(Date:3/1/2017)... PRUSSIA, Pa. , March 1, 2017  Global ... it has completed the largest ever Chronic Inflammatory Demyelinating ... A nd T reatment with H ... designed to demonstrate the efficacy, safety and tolerability of ... Hizentra ® (Immune Globulin Subcutaneous [Human]), compared with ...
Breaking Medicine Technology:
Cached News: